Astrocytic target mechanisms in epilepsy

Current Medicinal Chemistry

Volumn 21, Issue 6, 2014, Pages 755-763

  Heja L ^a  

^a INSTITUTE OF MATERIALS AND ENVIRONMENTAL CHEMISTRY   (Hungary)

Author keywords

Astrocytes; Blood brain barrier; Epilepsy; Gap junctions; Gliotransmission; Inflammation

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CEFTRIAXONE; CLOBAZAM; DEXAMETHASONE; ETIRACETAM; GLUTAMIC ACID; MICRORNA; SALAZOSULFAPYRIDINE;

4 AMINOBUTYRIC ACID RELEASE; ANTICONVULSANT THERAPY; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD VESSEL TONE; DRUG TARGETING; EPILEPSY; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; GAP JUNCTION; GENE EXPRESSION PROFILING; GLIA CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NERVE CELL EXCITABILITY; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER UPTAKE; NONHUMAN; SIGNAL TRANSDUCTION; STIMULUS SECRETION COUPLING; TARGET CELL;

ANIMALS; ASTROCYTES; EPILEPSY; GLUTAMATES; HUMANS;

EID: 84893301571     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867320666131119160445     Document Type: Article

References (131)

1. Perea, G.; Navarrete, M.; Araque, A. Tripartite synapses: astrocytes process and control synaptic information. Trends. Neurosci., 2009, 32, 421-431.
2. Hawkins, B.T. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease. Pharmacol. Rev., 2005, 57, 173-185.
3. Parpura, V.; Heneka, M.T.; Montana, V.; Oliet, S.H.R.; Schousboe, A.; Haydon, P.G.; Stout, R.F.; Spray, D.C.; Reichenbach, A.; Pannicke, T.; Pekny, M.; Pekna, M.; Zorec, R.; Verkhratsky, A. Glial cells in (patho)physiology. J. Neurochem., 2012, 121, 4-27.
4. Foerster, O.; Penfield, W. The Strudtural Basis of Traumatic Epilepsy and Results of Radical Operation. Brain, 1930, 53, 99-119.
5. De Lanerolle, N.C.; Lee, T.; Spencer, D.D. Astrocytes and Epilepsy. Neurotherapeutics, 2010, 7, 424-438.
6. Steinhäuser, C.; Seifert, G. Astrocyte dysfunction in epilepsy. In: Jasper's Basic Mechanisms of the Epilepsies; Noebels, J.; Avoli, M.; Rogawski, M.; Olsen, R.; Delgado-Escueta, A., Eds.; National Center for Biotechnology Information (US); 2012, 261-281.
7. Nedergaard, M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science, 1994, 263, 1768-1771.
8. Liu, Y.H.; Wang, L.; Wei, L.C.; Huang, Y.G.; Chen, L.W. Upregulation of D-serine might induce GABAergic neuronal degeneration in the cerebral cortex and hippocampus in the mouse pilocarpine model of epilepsy. Neurochem. Res., 2009, 34, 1209-1218.
9. Boison, D.; Stewart, K.A. Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation. Biochem. Pharmacol., 2009, 78, 1428-1437.
10. Héja, L.; Nyitrai, G.; Kékesi, O.; Dobolyi, A.; Szabó, P.; Fiáth, R.; Ulbert, I.; Pál-Szenthe, B.; Palkovits, M.; Kardos, J. Astrocytes convert network excitation to tonic inhibition of neurons. BMC Biol., 2012, 10, 26.
11. Héja, L.; Barabás, P.; Nyitrai, G.; Kékesi, K.A.; Lasztóczi, B.; Toke, O.; Tárkányi, G.; Madsen, K.; Schousboe, A.; Dobolyi, A.; Palkovits, M.; Kardos, J. Glutamate uptake triggers transportermediated GABA release from astrocytes. PLoS One, 2009, 4, e7153.
12. Rouach, N.; Koulakoff, A.; Abudara, V.; Willecke, K.; Giaume, C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science, 2008, 322, 1551-1555.
13. Timofeev, I.; Bazhenov, M.; Sejnowski, T.; Steriade, M. Cortical hyperpolarization-activated depolarizing current takes part in the generation of focal paroxysmal activities. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 9533-9537.
14. Amzica, F.; Massimini, M. Glial and neuronal interactions during slow wave and paroxysmal activities in the neocortex. Cereb. Cortex, 2002, 12, 1101-1113.
15. Kovács, R.; Heinemann, U.; Steinhäuser, C. Mechanisms underlying blood-brain barrier dysfunction in brain pathology and epileptogenesis: role of astroglia. Epilepsia, 2012, 53 Suppl 6, 53-59.
16. Ravizza, T.; Balosso, S.; Vezzani, A. Inflammation and prevention of epileptogenesis. Neurosci. Lett., 2011, 497, 223-230.
17. Héja, L.; Karacs, K.; Kardos, J. Role for GABA and Glu plasma membrane transporters in the interplay of inhibitory and excitatory neurotransmission. Curr. Top. Med. Chem., 2006, 6, 989-995.
18. Glass, M.; Dragunow, M. Neurochemical and morphological changes associated with human epilepsy. Brain Res. Brain Res. Rev., 1995, 21, 29-41.
19. Cavus, I.; Kasoff, W.S.; Cassaday, M.P.; Jacob, R.; Gueorguieva, R.; Sherwin, R.S.; Krystal, J.H.; Spencer, D.D.; Abi-Saab, W.M. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol., 2005, 57, 226-235.
20. During, M.J.; Spencer, D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet, 1993, 341, 1607-1610.
21. Danbolt, N.C. Glutamate uptake. Prog. Neurobiol., 2001, 65, 1-105.
22. Mathern, G.W.; Mendoza, D.; Lozada, A.; Pretorius, J.K.; Dehnes, Y.; Danbolt, N.C.; Nelson, N.; Leite, J.P.; Chimelli, L.; Born, D.E.; Sakamoto, A.C.; Assirati, J.A.; Fried, I.; Peacock, W.J.; Ojemann, G.A.; Adelson, P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology, 1999, 52, 453-472.
23. Proper, E.A.; Hoogland, G.; Kappen, S.M.; Jansen, G.H.; Rensen, M.G.A.; Schrama, L.H.; van Veelen, C.W.M.; van Rijen, P.C.; van Nieuwenhuizen, O.; Gispen, W.H.; de Graan, P.N. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain, 2002, 125, 32-43.
24. Sarac, S.; Afzal, S.; Broholm, H.; Madsen, F.F.; Ploug, T.; Laursen, H. Excitatory amino acid transporters EAAT-1 and EAAT-2 in temporal lobe and hippocampus in intractable temporal lobe epilepsy. APMIS, 2009, 117, 291-301.
25. Eid, T.; Thomas, M.J.; Spencer, D.D.; Rundén-Pran, E.; Lai, J.C.K.; Malthankar, G.V.; Kim, J.H.; Danbolt, N.C.; Ottersen, O.P.; de Lanerolle, N.C. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet, 2004, 363, 28-37.
26. Bjørnsen, L.P.; Eid, T.; Holmseth, S.; Danbolt, N.C.; Spencer, D.D.; de Lanerolle, N.C. Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures. Neurobiol. Dis., 2007, 25, 319-330.
27. Tanaka, K.; Watase, K.; Manabe, T.; Yamada, K.; Watanabe, M.; Takahashi, K.; Iwama, H.; Nishikawa, T.; Ichihara, N.; Kikuchi, T.; Okuyama, S.; Kawashima, N.; Hori, S.; Takimoto, M.; Wada, K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science, 1997, 276, 1699-1702.
28. Watanabe, T.; Morimoto, K.; Hirao, T.; Suwaki, H.; Watase, K.; Tanaka, K. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res., 1999, 845, 92-96.
29. Lee, S.G.; Su, Z.Z.; Emdad, L.; Gupta, P.; Sarkar, D.; Borjabad, A.; Volsky, D.J.; Fisher, P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem., 2008, 283, 13116-13123.
30. Goodrich, G.S.; Kabakov, A.Y.; Hameed, M.Q.; Dhamne, S.C.; Rosenberg, P.A.; Rotenberg, A. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter GLT-1, reduces regional gliosis, and reduces posttraumatic seizures in the rat. J. Neurotrauma, 2013, doi: 10.1089/neu.2012.2712.
31. Kong, Q.; Takahashi, K.; Schulte, D.; Stouffer, N.; Lin, Y.; Lin, C.L.G. Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus. Neurobiol. Dis., 2012, 47, 145-154.
32. Bak, L.K.; Schousboe, A.; Waagepetersen, H.S. The glutamate/ GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem., 2006, 98, 641-653.
33. Papageorgiou, I.E.; Gabriel, S.; Fetani, A.F.; Kann, O.; Heinemann, U. Redistribution of astrocytic glutamine synthetase in the hippocampus of chronic epileptic rats. Glia, 2011, 59, 1706-1718.
34. Van der Hel, W.S.; Notenboom, R.G.E.; Bos, I.W.M.; van Rijen, P.C.; van Veelen, C.W.M.; de Graan, P.N.E. Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy. Neurology, 2005, 64, 326-333.
35. Perez, E.L.; Lauritzen, F.; Wang, Y.; Lee, T.S.W.; Kang, D.; Zaveri, H.P.; Chaudhry, F.A.; Ottersen, O.P.; Bergersen, L.H.; Eid, T. Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy. Neurobiol. Dis., 2012, 47, 331-337.
36. Liang, S.L.; Carlson, G.C.; Coulter, D.A. Dynamic regulation of synaptic GABA release by the glutamate-glutamine cycle in hippocampal area CA1. J. Neurosci., 2006, 26, 8537-8548.
37. Fricke, M.N.; Jones-Davis, D.M.; Mathews, G.C. Glutamine uptake by System A transporters maintains neurotransmitter GABA synthesis and inhibitory synaptic transmission. J. Neurochem., 2007, 102, 1895-1904.
38. Bryant, A.S.; Li, B.; Beenhakker, M.P.; Huguenard, J.R. Maintenance of thalamic epileptiform activity depends on the astrocytic glutamate-glutamine cycle. J. Neurophysiol., 2009, 102, 2880-2888.
39. Ortinski, P.I.; Dong, J.; Mungenast, A.; Yue, C.; Takano, H.; Watson, D.J.; Haydon, P.G.; Coulter, D.A. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci., 2010, 13, 584-591.
40. Yang, S.; Cox, C.L. Attenuation of inhibitory synaptic transmission by glial dysfunction in rat thalamus. Synapse, 2011, 65, 1298-1308.
41. Hamilton, N.B.; Attwell, D. Do astrocytes really exocytose neurotransmitters? Nat. Rev. Neurosci., 2010, 11, 227-238.
42. Henneberger, C.; Papouin, T.; Oliet, S.H.R.; Rusakov, D.A. Longterm potentiation depends on release of D-serine from astrocytes. Nature, 2010, 463, 232-236.
43. Angulo, M.C.; Le Meur, K.; Kozlov, A.S.; Charpak, S.; Audinat, E. GABA, a forgotten gliotransmitter. Prog. Neurobiol., 2008, 86, 297-303.
44. Parpura, V.; Basarsky, T.A.; Liu, F.; Jeftinija, K.; Jeftinija, S.; Haydon, P.G. Glutamate-mediated astrocyte-neuron signalling. Nature, 1994, 369, 744-747.
45. Angulo, M.C.; Kozlov, A.S.; Charpak, S.; Audinat, E. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J. Neurosci., 2004, 24, 6920-6927.
46. Kang, N.; Xu, J.; Xu, Q.; Nedergaard, M.; Kang, J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J. Neurophysiol., 2005, 94, 4121-4130.
47. Tian, G.F.; Azmi, H.; Takano, T.; Xu, Q.; Peng, W.; Lin, J.; Oberheim, N.; Lou, N.; Wang, X.; Zielke, H.R.; Kang, J.; Nedergaard, M. An astrocytic basis of epilepsy. Nat. Med., 2005, 11, 973-981.
48. Buckingham, S.C.; Campbell, S.L.; Haas, B.R.; Montana, V.; Robel, S.; Ogunrinu, T.; Sontheimer, H. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med., 2011, 17, 1269-1274.
49. Unichenko, P.; Myakhar, O.; Kirischuk, S. Intracellular Na+ concentration influences short-term plasticity of glutamate transporter-mediated currents in neocortical astrocytes. Glia, 2012, 60, 605-614.
50. Richerson, G.B.; Wu, Y. Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. J. Neurophysiol., 2003, 90, 1363-1374.
51. Brickley, S.G.; Mody, I. Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron, 2012, 73, 23-34.
52. Laschet, J.; Grisar, T.; Bureau, M.; Guillaume, D. Characteristics of putrescine uptake and subsequent GABA formation in primary cultured astrocytes from normal C57BL/6J and epileptic DBA/2J mouse brain cortices. Neuroscience, 1992, 48, 151-157.
53. Lee, T.S.S.; Bjørnsen, L.P.; Paz, C.; Kim, J.H.; Spencer, S.S.; Spencer, D.D.; Eid, T.; de Lanerolle, N.C.; Bjornsen, L.P. GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus. Acta Neuropathol., 2006, 111, 351-363.
54. Bordey, A.; Spencer, D.D. Distinct electrophysiological alterations in dentate gyrus versus CA1 glial cells from epileptic humans with temporal lobe sclerosis. Epilepsy Res., 2004, 59, 107-122.
55. Schousboe, A.; Madsen, K.K.; White, H.S. GABA transport inhibitors and seizure protection: the past and future. Future Med. Chem., 2011, 3, 183-187.
56. Ueda, Y.; Doi, T.; Nagatomo, K.; Tokumaru, J.; Takaki, M.; Willmore, L.J. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection. Brain Res., 2007, 1151, 55-61.
57. Doi, T.; Ueda, Y.; Tokumaru, J.; Willmore, L.J. Molecular regulation of glutamate and GABA transporter proteins by clobazam during epileptogenesis in Fe(+++)-induced epileptic rats. Brain Res. Mol. Brain. Res., 2005, 142, 91-96.
58. Serrano, A.; Haddjeri, N.; Lacaille, J.C.; Robitaille, R. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J. Neurosci., 2006, 26, 5370-5382.
59. Maitre, M.; Ciesielski, L.; Lehmann, A.; Kempf, E.; Mandel, P. Protective effect of adenosine and nicotinamide against audiogenic seizure. Biochem. Pharmacol., 1974, 23, 2807-2816.
60. Boison, D. The adenosine kinase hypothesis of epileptogenesis. Prog. Neurobiol., 2008, 84, 249-262.
61. Li, T.; Ren, G.; Lusardi, T.; Wilz, A.; Lan, J.Q.; Iwasato, T.; Itohara, S.; Simon, R.P.; Boison, D. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J. Clin. Invest., 2008, 118, 571-582.
62. Boison, D. Adenosine dysfunction in epilepsy. Glia, 2012, 60, 1234-1243.
63. Santiago, M.F.; Veliskova, J.; Patel, N.K.; Lutz, S.E.; Caille, D.; Charollais, A.; Meda, P.; Scemes, E. Targeting pannexin1 improves seizure outcome. PLoS One, 2011, 6, e25178.
64. Cunha, R.A.; Ferré, S.; Vaugeois, J.M.; Chen, J.F. Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr. Pharm. Des., 2008, 14, 1512-1524.
65. Matos, M.; Augusto, E.; Dos Santos-Rodrigues, A.; Schwarzschild, M.A.; Chen, J.F.; Cunha, R.A.; Agostinho, P. Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia, 2012, 60, 702-716.
66. Klaft, Z.J.; Schulz, S.B.; Maslarova, A.; Gabriel, S.; Heinemann, U.; Gerevich, Z. Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats. Epilepsia, 2012, 53, 1978-1986.
67. Engel, T.; Gomez-Villafuertes, R.; Tanaka, K.; Mesuret, G.; Sanz-Rodriguez, A.; Garcia-Huerta, P.; Miras-Portugal, M.T.; Henshall, D.C.; Diaz-Hernandez, M. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J., 2012, 26, 1616-1628.
68. Heinemann, U.; Lux, H.D. Ceiling of stimulus induced rises in extracellular potassium concentration in the cerebral cortex of cat. Brain Res., 1977, 120, 231-249.
69. Simard, M.; Nedergaard, M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience, 2004, 129, 877-896.
70. Gigout, S.; Louvel, J.; Kawasaki, H.; D'Antuono, M.; Armand, V.; Kurcewicz, I.; Olivier, A.; Laschet, J.; Turak, B.; Devaux, B.; Pumain, R.; Avoli, M. Effects of gap junction blockers on human neocortical synchronization. Neurobiol. Dis., 2006, 22, 496-508.
71. Gajda, Z.; Hermesz, E.; Gyengési, E.; Szupera, Z.; Szente, M. The functional significance of gap junction channels in the epileptogenicity and seizure susceptibility of juvenile rats. Epilepsia, 2006, 47, 1009-1022.
72. Nagy, J.I.; Rash, J.E. Astrocyte and oligodendrocyte connexins of the glial syncytium in relation to astrocyte anatomical domains and spatial buffering. Cell Commun. Adhes., 2003, 10, 401-406.
73. Akbarpour, B.; Sayyah, M.; Babapour, V.; Mahdian, R.; Beheshti, S.; Kamyab, A.R. Expression of connexin 30 and connexin 32 in hippocampus of rat during epileptogenesis in a kindling model of epilepsy. Neurosci. Bull., 2012, 28, 729-736.
74. Mylvaganam, S.; Zhang, L.; Wu, C.; Zhang, Z.J.; Samoilova, M.; Eubanks, J.; Carlen, P.L.; Poulter, M.O. Hippocampal seizures alter the expression of the pannexin and connexin transcriptome. J. Neurochem., 2010, 112, 92-102.
75. Samoilova, M.; Li, J.; Pelletier, M.R.; Wentlandt, K.; Adamchik, Y.; Naus, C.C.; Carlen, P.L. Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expression. J. Neurochem., 2003, 86, 687-699.
76. Jahromi, S.S.; Wentlandt, K.; Piran, S.; Carlen, P.L. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J. Neurophysiol., 2002, 88, 1893-1902.
77. David, Y.; Cacheaux, L.P.; Ivens, S.; Lapilover, E.; Heinemann, U.; Kaufer, D.; Friedman, A. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? J. Neurosci., 2009, 29, 10588-10599.
78. Elisevich, K.; Rempel, S.A.; Smith, B.; Hirst, K. Temporal profile of connexin 43 mRNA expression in a tetanus toxin-induced seizure disorder. Mol. Chem. Neuropathol., 1998, 35, 23-37.
79. Xu, L.; Zeng, L.H.; Wong, M. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol. Dis., 2009, 34, 291-299.
80. Bostanci, M.O.; Baǧirici, F. Anticonvulsive effects of carbenoxolone on penicillin-induced epileptiform activity: an in vivo study. Neuropharmacology, 2007, 52, 362-367.
81. Pannasch, U.; Vargová, L.; Reingruber, J.; Ezan, P.; Holcman, D.; Giaume, C.; Syková, E.; Rouach, N. Astroglial networks scale synaptic activity and plasticity. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 8467-8472.
82. Wallraff, A.; Köhling, R.; Heinemann, U.; Theis, M.; Willecke, K.; Steinhäuser, C. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J. Neurosci., 2006, 26, 5438-5447.
83. Bushong, E.A.; Martone, M.E.; Jones, Y.Z.; Ellisman, M.H. Protoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains. J. Neurosci., 2002, 22, 183-192.
84. Oberheim, N.A.; Tian, G.F.; Han, X.; Peng, W.; Takano, T.; Ransom, B.; Nedergaard, M. Loss of astrocytic domain organization in the epileptic brain. J. Neurosci., 2008, 28, 3264-3276.
85. Bratz, E. Ammonshornbefunde bei Epileptischen. Arch. Psychiatr. Nervenkr., 1899, 31, 820-836.
86. Ndode-Ekane, X.E.; Hayward, N.; Gröhn, O.; Pitkänen, A. Vascular changes in epilepsy: functional consequences and association with network plasticity in pilocarpine-induced experimental epilepsy. Neuroscience, 2010, 166, 312-332.
87. Shlosberg, D.; Benifla, M.; Kaufer, D.; Friedman, A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol., 2010, 6, 393-403.
88. Seiffert, E.; Dreier, J.P.; Ivens, S.; Bechmann, I.; Tomkins, O.; Heinemann, U.; Friedman, A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci., 2004, 24, 7829-7836.
89. Van Vliet, E.A.; da Costa Araújo, S.; Redeker, S.; van Schaik, R.; Aronica, E.; Gorter, J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain, 2007, 130, 521-534.
90. Frigerio, F.; Frasca, A.; Weissberg, I.; Parrella, S.; Friedman, A.; Vezzani, A.; Noé, F.M. Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia, 2012, 53, 1887-1897.
91. Braganza, O.; Bedner, P.; Hüttmann, K.; von Staden, E.; Friedman, A.; Seifert, G.; Steinhäuser, C. Albumin is taken up by hippocampal NG2 cells and astrocytes and decreases gap junction coupling. Epilepsia, 2012, 53, 1898-1906.
92. Ivens, S.; Kaufer, D.; Flores, L.P.; Bechmann, I.; Zumsteg, D.; Tomkins, O.; Seiffert, E.; Heinemann, U.; Friedman, A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain, 2007, 130, 535-547.
93. Marchi, N.; Angelov, L.; Masaryk, T.; Fazio, V.; Granata, T.; Hernandez, N.; Hallene, K.; Diglaw, T.; Franic, L.; Najm, I.; Janigro, D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia, 2007, 48, 732-742.
94. Zurolo, E.; de Groot, M.; Iyer, A.; Anink, J.; van Vliet, E.A.; Heimans, J.J.; Reijneveld, J.C.; Gorter, J.A.; Aronica, E. Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 -. J. Neuroinflammation, 2012, 9, 280.
95. Lee, K.R.; Drury, I.; Vitarbo, E.; Hoff, J.T. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J. Neurosurg., 1997, 87, 73-78.
96. Maggio, N.; Shavit, E.; Chapman, J.; Segal, M. Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J. Neurosci., 2008, 28, 732-736.
97. Maggio, N.; Blatt, I.; Vlachos, A.; Tanne, D.; Chapman, J.; Segal, M. Treating seizures and epilepsy with anticoagulants? Front. Cell. Neurosci., 2013, 7, 19.
98. Zonta, M.; Sebelin, A.; Gobbo, S.; Fellin, T.; Pozzan, T.; Carmignoto, G. Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. J. Physiol., 2003, 553, 407-414.
99. Kowiański, P.; Lietzau, G.; Steliga, A.; Waśkow, M.; Moryś, J. The astrocytic contribution to neurovascular coupling - Still more questions than answers? Neurosci. Res., 2013, 75, 171-183.
100. Pinard, E.; Riche, D.; Puiroud, S.; Seylaz, J. Theophylline reduces cerebral hyperaemia and enhances brain damage induced by seizures. Brain Res., 1990, 511, 303-309.
101. Vezzani, A.; Friedman, A. Brain inflammation as a biomarker in epilepsy. Biomark. Med., 2011, 5, 607-614.
102. Dong, Y.; Benveniste, E.N. Immune function of astrocytes. Glia, 2001, 36, 180-190.
103. De Simoni, M.G.; Perego, C.; Ravizza, T.; Moneta, D.; Conti, M.; Marchesi, F.; De Luigi, A.; Garattini, S.; Vezzani, A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci., 2000, 12, 2623-2633.
104. Minami, M.; Kuraishi, Y.; Satoh, M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun., 1991, 176, 593-598.
105. Vezzani, A.; Moneta, D.; Richichi, C.; Aliprandi, M.; Burrows, S.J.; Ravizza, T.; Perego, C.; De Simoni, M.G. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia, 2002, 43 Suppl 5, 30-35.
106. Maroso, M.; Balosso, S.; Ravizza, T.; Liu, J.; Aronica, E.; Iyer, A.M.; Rossetti, C.; Molteni, M.; Casalgrandi, M.; Manfredi, A.A.; Bianchi, M.E.; Vezzani, A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med., 2010, 16, 413-419.
107. Tannahill, G.M.; Curtis, A.M.; Adamik, J.; Palsson-McDermott, E.M.; McGettrick, A.F.; Goel, G.; Frezza, C.; Bernard, N.J.; Kelly, B.; Foley, N.H.; Zheng, L.; Gardet, A.; Tong, Z.; Jany, S.S.; Corr, S.C.; Haneklaus, M.; Caffrey, B.E.; Pierce, K.; Walmsley, S.; Beasley, F.C.; Cummins, E.; Nizet, V.; Whyte, M.; Taylor, C.T.; Lin, H.; Masters, S.L.; Gottlieb, E.; Kelly, V.P.; Clish, C.; Auron, P.E.; Xavier, R.J.; O'Neill, L.A. Succinate is an inflammatory signal that induces IL-1- through HIF-1-. Nature, 2013, 496, 238-242.
108. Molnár, T.; Héja, L.; Emri, Z.; Simon, A.; Nyitrai, G.; Pál, I.; Kardos, J. Activation of astroglial calcium signaling by endogenous metabolites succinate and gamma-hydroxybutyrate in the nucleus accumbens. Front. Neuroenergetics, 2011, 3, 7.
109. Molnár, T.; Dobolyi, A.; Nyitrai, G.; Barabás, P.; Héja, L.; Emri, Z.; Palkovits, M.; Kardos, J. Calcium signals in the nucleus accumbens: Activation of astrocytes by ATP and succinate. BMC Neurosci., 2011, 12, 96.
110. Crespel, A.; Coubes, P.; Rousset, M.C.; Brana, C.; Rougier, A.; Rondouin, G.; Bockaert, J.; Baldy-Moulinier, M.; Lerner-Natoli, M. Inflammatory reactions in human medial temporal lobe epilepsy with hippocampal sclerosis. Brain Res., 2002, 952, 159-169.
111. Ravizza, T.; Gagliardi, B.; Noé, F.; Boer, K.; Aronica, E.; Vezzani, A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis., 2008, 29, 142-160.
112. Sayyah, M.; Najafabadi, I.T.; Beheshti, S.; Majzoob, S. Lipopolysaccharide retards development of amygdala kindling but does not affect fully-kindled seizures in rats. Epilepsy Res., 2003, 57, 175-180.
113. Heida, J.G.; Pittman, Q.J. Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia, 2005, 46, 1906-1913.
114. Galic, M.A.; Riazi, K.; Heida, J.G.; Mouihate, A.; Fournier, N.M.; Spencer, S.J.; Kalynchuk, L.E.; Teskey, G.C.; Pittman, Q.J. Postnatal inflammation increases seizure susceptibility in adult rats. J. Neurosci., 2008, 28, 6904-6913.
115. Kovács, Z.; Czurkó, A.; Kékesi, K.A.; Juhász, G. Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG/Rij rats. Brain Res. Bull., 2011, 85, 410-416.
116. Kovács, Z.; Kékesi, K.A.; Szilágyi, N.; Abrahám, I.; Székács, D.; Király, N.; Papp, E.; Császár, I.; Szego, E.; Barabás, K.; Péterfy, H.; Erdei, A.; Bártfai, T.; Juhász, G. Facilitation of spike-wave discharge activity by lipopolysaccharides in Wistar Albino Glaxo/Rijswijk rats. Neuroscience, 2006, 140, 731-742.
117. Jiang, J.; Quan, Y.; Ganesh, T.; Pouliot, W.A.; Dudek, F.E.; Dingledine, R. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 3591-3596.
118. Ravizza, T.; Noé, F.; Zardoni, D.; Vaghi, V.; Sifringer, M.; Vezzani, A. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol. Dis., 2008, 31, 327-333.
119. Dubé, C.; Vezzani, A.; Behrens, M.; Bartfai, T.; Baram, T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol., 2005, 57, 152-155.
120. Auvin, S.; Shin, D.; Mazarati, A.; Sankar, R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia, 2010, 51 Suppl 3, 34-38.
121. Luo, X.; Li, D.; Cen, D.; He, Z.; Meng, Z.; Liang, L. Effect of intravenous immunoglobulin treatment on brain interferon-gamma and interleukin-6 levels in a rat kindling model. Epilepsy Res., 2010, 88, 162-167.
122. Matoth, I.; Pinto, F.; Sicsic, C.; Brenner, T. Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neurosci. Res., 2000, 38, 209-212.
123. Haghikia, A.; Ladage, K.; Hinkerohe, D.; Vollmar, P.; Heupel, K.; Dermietzel, R.; Faustmann, P.M. Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J. Neurosci. Res., 2008, 86, 1781-1788.
124. Gibbons, H.M.; Smith, A.M.; Teoh, H.H.; Bergin, P.M.; Mee, E.W.; Faull, R.L.M.; Dragunow, M. Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures. Neurobiol. Dis., 2011, 41, 96-103.
125. Tao, J.; Wu, H.; Lin, Q.; Wei, W.; Lu, X.H.; Cantle, J.P.; Ao, Y.; Olsen, R.W.; Yang, X.W.; Mody, I.; Sofroniew, M.V.; Sun, Y.E. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci., 2011, 31, 8306-8319.
126. Jimenez-Mateos, E.M.; Bray, I.; Sanz-Rodriguez, A.; Engel, T.; McKiernan, R.C.; Mouri, G.; Tanaka, K.; Sano, T.; Saugstad, J.A.; Simon, R.P.; Stallings, R.L.; Henshall, D.C. miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am. J. Pathol., 2011, 179, 2519-2532.
127. Aronica, E.; Fluiter, K.; Iyer, A.; Zurolo, E.; Vreijling, J.; van Vliet, E.A.; Baayen, J.C.; Gorter, J.A. Expression pattern of miR- 146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci., 2010, 31, 1100-1107.
128. Omran, A.; Peng, J.; Zhang, C.; Xiang, Q.L.; Xue, J.; Gan, N.; Kong, H.; Yin, F. Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia, 2012, 53, 1215-1224.
129. Galanopoulou, A.S.; Buckmaster, P.S.; Staley, K.J.; Moshé, S.L.; Perucca, E.; Engel, J.; Löscher, W.; Noebels, J.L.; Pitkänen, A.; Stables, J.; White, H.S.; O'Brien, T.J.; Simonato, M. Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia, 2012, 53, 571-582.
130. Clarkson, A.N.; Huang, B.S.; Macisaac, S.E.; Mody, I.; Carmichael, S.T. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature, 2010, 468, 305-309.
131. Marchi, N.; Granata, T.; Freri, E.; Ciusani, E.; Ragona, F.; Puvenna, V.; Teng, Q.; Alexopolous, A.; Janigro, D. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One, 2011, 6, e18200.